Skip to content

TSA vs RSA in Glenohumeral Osteoarthritis

Osteoarthritis of the Shoulder

This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    65 and up

Participation Criteria

Inclusion Criteria:

1. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:

1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
3. Activity modification
2. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
3. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
4. 65 years of age and older

Exclusion Criteria:

1. Active joint or systemic infection
2. Rotator cuff arthropathy
3. Significant muscle paralysis
4. Charcot's arthropathy
5. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
6. Unable to understand the consent form/process
7. Pregnancy
8. Psychiatric illness that precludes informed consent
9. Unwilling to be followed for the duration of the study
10. Retroversion cannot be surgically corrected to within 10 degrees of neutral
11. History of previous shoulder surgery on affected side

Study Location

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Martin Bouliane, MD

780-434-4859
The Ottawa Hospital
The Ottawa Hospital
Ottawa, Ontario
Canada

Contact Study Team

Primary Contact

Peter Lapner, MD

6137378899
Pan Am Clinic Foundation
Pan Am Clinic Foundation
Winnipeg, Manitoba
Canada

Contact Study Team

Primary Contact

Sheila McRae

204-925-7469
Kingston General Hospital (Site-Watkins 3)
Kingston General Hospital (Site-Watkins 3)
Kingston, Ontario
Canada

Contact Study Team

Primary Contact

Fiona Howells

[email protected]
613-549-6666
Study Sponsored By
Ottawa Hospital Research Institute
Participants Required
More Information
Study ID: NCT04228419